Clinical Trials Browser

Phase 3 × Urinary Bladder Neoplasms × Ropivacaine × Clear all

NCT02438852 2019-04-16

Continuous Infusion of Ropivacaine Hydrochloride in Reducing Pain After Surgery in Patients With Bladder Cancer

Phase 3 Withdrawn

Urinary Bladder Neoplasms, Pain, Postoperative